2022-2027 Global and Regional Narcolepsy Drug Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-73984 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Narcolepsy Drug market was valued at 169.17 Million USD in 2021 and will grow with a CAGR of 10.17% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of narcolepsy drug includes antioxidants type, stimulants type and other types, and the proportion of antioxidants type in 2016 is about 78% in the world. Narcolepsy drug is widely used for daytime extreme sleepiness, cataplexia and other field. The most proportion of narcolepsy drug is used for cataplexia, and the consumption proportion in 2016 is about 57%. By Market Verdors: Jazz Pharmaceuticals Teva Pharmaceutical Novartis Mylan By Types: Antioxidants Type Stimulants Type By Applications: Daytime Extreme Sleepiness Cataplexia Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Narcolepsy Drug Market Size Analysis from 2022 to 2027 1.5.1 Global Narcolepsy Drug Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Narcolepsy Drug Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Narcolepsy Drug Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Narcolepsy Drug Industry Impact Chapter 2 Global Narcolepsy Drug Competition by Types, Applications, and Top Regions and Countries 2.1 Global Narcolepsy Drug (Volume and Value) by Type 2.1.1 Global Narcolepsy Drug Consumption and Market Share by Type (2016-2021) 2.1.2 Global Narcolepsy Drug Revenue and Market Share by Type (2016-2021) 2.2 Global Narcolepsy Drug (Volume and Value) by Application 2.2.1 Global Narcolepsy Drug Consumption and Market Share by Application (2016-2021) 2.2.2 Global Narcolepsy Drug Revenue and Market Share by Application (2016-2021) 2.3 Global Narcolepsy Drug (Volume and Value) by Regions 2.3.1 Global Narcolepsy Drug Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Narcolepsy Drug Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Narcolepsy Drug Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Narcolepsy Drug Consumption by Regions (2016-2021) 4.2 North America Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) 4.10 South America Narcolepsy Drug Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Narcolepsy Drug Market Analysis 5.1 North America Narcolepsy Drug Consumption and Value Analysis 5.1.1 North America Narcolepsy Drug Market Under COVID-19 5.2 North America Narcolepsy Drug Consumption Volume by Types 5.3 North America Narcolepsy Drug Consumption Structure by Application 5.4 North America Narcolepsy Drug Consumption by Top Countries 5.4.1 United States Narcolepsy Drug Consumption Volume from 2016 to 2021 5.4.2 Canada Narcolepsy Drug Consumption Volume from 2016 to 2021 5.4.3 Mexico Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 6 East Asia Narcolepsy Drug Market Analysis 6.1 East Asia Narcolepsy Drug Consumption and Value Analysis 6.1.1 East Asia Narcolepsy Drug Market Under COVID-19 6.2 East Asia Narcolepsy Drug Consumption Volume by Types 6.3 East Asia Narcolepsy Drug Consumption Structure by Application 6.4 East Asia Narcolepsy Drug Consumption by Top Countries 6.4.1 China Narcolepsy Drug Consumption Volume from 2016 to 2021 6.4.2 Japan Narcolepsy Drug Consumption Volume from 2016 to 2021 6.4.3 South Korea Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 7 Europe Narcolepsy Drug Market Analysis 7.1 Europe Narcolepsy Drug Consumption and Value Analysis 7.1.1 Europe Narcolepsy Drug Market Under COVID-19 7.2 Europe Narcolepsy Drug Consumption Volume by Types 7.3 Europe Narcolepsy Drug Consumption Structure by Application 7.4 Europe Narcolepsy Drug Consumption by Top Countries 7.4.1 Germany Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.2 UK Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.3 France Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.4 Italy Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.5 Russia Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.6 Spain Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.7 Netherlands Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.8 Switzerland Narcolepsy Drug Consumption Volume from 2016 to 2021 7.4.9 Poland Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 8 South Asia Narcolepsy Drug Market Analysis 8.1 South Asia Narcolepsy Drug Consumption and Value Analysis 8.1.1 South Asia Narcolepsy Drug Market Under COVID-19 8.2 South Asia Narcolepsy Drug Consumption Volume by Types 8.3 South Asia Narcolepsy Drug Consumption Structure by Application 8.4 South Asia Narcolepsy Drug Consumption by Top Countries 8.4.1 India Narcolepsy Drug Consumption Volume from 2016 to 2021 8.4.2 Pakistan Narcolepsy Drug Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Narcolepsy Drug Market Analysis 9.1 Southeast Asia Narcolepsy Drug Consumption and Value Analysis 9.1.1 Southeast Asia Narcolepsy Drug Market Under COVID-19 9.2 Southeast Asia Narcolepsy Drug Consumption Volume by Types 9.3 Southeast Asia Narcolepsy Drug Consumption Structure by Application 9.4 Southeast Asia Narcolepsy Drug Consumption by Top Countries 9.4.1 Indonesia Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.2 Thailand Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.3 Singapore Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.4 Malaysia Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.5 Philippines Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.6 Vietnam Narcolepsy Drug Consumption Volume from 2016 to 2021 9.4.7 Myanmar Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 10 Middle East Narcolepsy Drug Market Analysis 10.1 Middle East Narcolepsy Drug Consumption and Value Analysis 10.1.1 Middle East Narcolepsy Drug Market Under COVID-19 10.2 Middle East Narcolepsy Drug Consumption Volume by Types 10.3 Middle East Narcolepsy Drug Consumption Structure by Application 10.4 Middle East Narcolepsy Drug Consumption by Top Countries 10.4.1 Turkey Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.3 Iran Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.5 Israel Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.6 Iraq Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.7 Qatar Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.8 Kuwait Narcolepsy Drug Consumption Volume from 2016 to 2021 10.4.9 Oman Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 11 Africa Narcolepsy Drug Market Analysis 11.1 Africa Narcolepsy Drug Consumption and Value Analysis 11.1.1 Africa Narcolepsy Drug Market Under COVID-19 11.2 Africa Narcolepsy Drug Consumption Volume by Types 11.3 Africa Narcolepsy Drug Consumption Structure by Application 11.4 Africa Narcolepsy Drug Consumption by Top Countries 11.4.1 Nigeria Narcolepsy Drug Consumption Volume from 2016 to 2021 11.4.2 South Africa Narcolepsy Drug Consumption Volume from 2016 to 2021 11.4.3 Egypt Narcolepsy Drug Consumption Volume from 2016 to 2021 11.4.4 Algeria Narcolepsy Drug Consumption Volume from 2016 to 2021 11.4.5 Morocco Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 12 Oceania Narcolepsy Drug Market Analysis 12.1 Oceania Narcolepsy Drug Consumption and Value Analysis 12.2 Oceania Narcolepsy Drug Consumption Volume by Types 12.3 Oceania Narcolepsy Drug Consumption Structure by Application 12.4 Oceania Narcolepsy Drug Consumption by Top Countries 12.4.1 Australia Narcolepsy Drug Consumption Volume from 2016 to 2021 12.4.2 New Zealand Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 13 South America Narcolepsy Drug Market Analysis 13.1 South America Narcolepsy Drug Consumption and Value Analysis 13.1.1 South America Narcolepsy Drug Market Under COVID-19 13.2 South America Narcolepsy Drug Consumption Volume by Types 13.3 South America Narcolepsy Drug Consumption Structure by Application 13.4 South America Narcolepsy Drug Consumption Volume by Major Countries 13.4.1 Brazil Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.2 Argentina Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.3 Columbia Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.4 Chile Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.5 Venezuela Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.6 Peru Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Narcolepsy Drug Consumption Volume from 2016 to 2021 13.4.8 Ecuador Narcolepsy Drug Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Narcolepsy Drug Business 14.1 Jazz Pharmaceuticals 14.1.1 Jazz Pharmaceuticals Company Profile 14.1.2 Jazz Pharmaceuticals Narcolepsy Drug Product Specification 14.1.3 Jazz Pharmaceuticals Narcolepsy Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Teva Pharmaceutical 14.2.1 Teva Pharmaceutical Company Profile 14.2.2 Teva Pharmaceutical Narcolepsy Drug Product Specification 14.2.3 Teva Pharmaceutical Narcolepsy Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Novartis 14.3.1 Novartis Company Profile 14.3.2 Novartis Narcolepsy Drug Product Specification 14.3.3 Novartis Narcolepsy Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Mylan 14.4.1 Mylan Company Profile 14.4.2 Mylan Narcolepsy Drug Product Specification 14.4.3 Mylan Narcolepsy Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Narcolepsy Drug Market Forecast (2022-2027) 15.1 Global Narcolepsy Drug Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Narcolepsy Drug Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Narcolepsy Drug Value and Growth Rate Forecast (2022-2027) 15.2 Global Narcolepsy Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Narcolepsy Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Narcolepsy Drug Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Narcolepsy Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Narcolepsy Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Narcolepsy Drug Consumption Forecast by Type (2022-2027) 15.3.2 Global Narcolepsy Drug Revenue Forecast by Type (2022-2027) 15.3.3 Global Narcolepsy Drug Price Forecast by Type (2022-2027) 15.4 Global Narcolepsy Drug Consumption Volume Forecast by Application (2022-2027) 15.5 Narcolepsy Drug Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000